This study aimed to clarify the association between the TP53 rs1625895 polymorphism and the efficiency of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone) therapy in 106 patients with diffuse large B cell lymphoma (DLBCL). All patients received six to eight courses of R-...
Corrigendum to "Berberine derivative DCZ0358 induced oxidative damage by ROS-mediated JNK signaling in DLBCL cells" [Int. Immunopharmacol. 125(Part A) (202... Q Feng,K Hu,H Hu,... - 《International Immunopharmacology》 被引量: 0发表: 0年 Corrigendum to "The sphingolipid degradation product ...
Richter Syndrome (RS): Genome-Wide Promoter Methylation Profile Differs From De Novo Diffuse Large B-Cell Lymphoma (DLBCL) and Affects Genes Involved in Stem-Cell Maintenance and TP53 PathwayIvo Kwee
Forest plots for association of rs2509049 with DLBCL, FL and all B-cell lymphomas.Karla L. BretherickJohanna M. SchuetzLindsay M. MortonMark P. PurdueLucía CondeRichard P. GallagherJoseph M. ConnorsRandy D. GascoyneBrian R. BerryBruce Armstrong...
Association between DLBCL 10 year overall survival and TAP2 (rs241447).Kaspar, René NielsenRudi, SteffensenMette, Dahl BendtsenMaria, RodrigoDomingoJohn, BaechThure, Mors HaunstrupKim, Steve BergkvistAlexander, SchmitzJulie, Stoeveve Boedker